Mes données de santé

Informacijska stranica za pacijente liječene u mreži Unicancer ili uključene u klinička ispitivanja mreže Unicancer

O ovoj stranici

Ciljevi

Primary objective

Comparison of the prevalence of molecular alterations between the post-treatment versus pre-treatment tumor samples of all patients.

 

Secondary objectives

* Comparison of the prevalence of molecular alterations between the post-treatment versus pre-treatment tumor samples of patients with paired samples (post- and pre-treatment)

* Identification of molecular alterations in the pre-treatment samples associated with the clinical benefit (RECIST responses, progression-free survival PFS)

* Identification of expression signature in the pre-treatment samples associated with the clinical benefit (RECIST1.1 responses, progression-free survival PFS)

* Identification of molecular alterations therapeutically “actionable” (therapeutic target of or marker predictive for response to currently available or under development drugs) in the post- and the pre-treatment samples

*Percentage of patients with molecular alterations therapeutically “actionable” in the post- and the pre-treatment samples

Voditelj obrade

Institut Paoli Calmettes

232 Boulevard Sainte Marguerite

13273 Marseille Cedex 09

Kategorije korištenih podataka
Données d’identification (sans donnée nominative) / Données de santé / Données génétiques / Antécédents familiaux
Origine de données utilisées
Soins
Institut Paoli Calmettes (Marseille)
Populacija koja je predmet istraživanja ili obrade podataka

The main inclusion criteria include female patients previously treated in our institution, with pathologically-proven HR+/HER2- mBC, treated with hormone therapy combined with CDK4/6 inhibitors, with a metastatic/tumor sample (FFPE and/or frozen) available and collected before and/or after this treatment, with clinico-pathological annotations including the dates of treatments, objective responses, and progression-free survival, and with signed informed consent for enrolment and molecular analyses. All patients v and not lost to follow-up will be sent an individual information note before launching the project to advertise them of the project.

Pravna osnova

Traitement de données mené dans l'intérêt public dans le domaine de la santé publique (article 6.1e et 9.2.j du Règlement (UE) n°2016/679)

Interni i vanjski primatelji podataka

Institut Paoli Calmettes

Datum početka istraživanja
08/07/2021
Razdoblje čuvanja podataka

Les données seront conservées pendant la durée légale en vigueur ou tant qu'elles présenteront un intérêt scientifique 

Kako biste zaštitili svoje zdravstvene podatke, preporučuje se da u ovom obrascu ne otkrivate osobne zdravstvene informacije o sebi ili članu obitelji.
Pozivamo vas da navedete ustanovu u kojoj se liječite i osigurat ćemo uspostavljanje odgovarajuće veze kako bismo zajamčili ostvarivanje vašeg zahtjeva.
CAPTCHA
Image CAPTCHA
Enter the characters shown in the image.
Cette question sert à vérifier si vous êtes un visiteur humain ou non afin d'éviter les soumissions de pourriel (spam) automatisées.

Informacije prikupljene u upitniku ne pohranjuju se na ovoj web stranici, već se šalju voditelju obrade podataka navedenom u obrascu za istraživanje. Ovi se podaci prikupljaju radi obrade vašeg zahtjeva za ostvarivanje prava.

Podaci označeni zvjezdicom u upitniku moraju se obavezno navesti za slanje obrasca i obradu vašeg zahtjeva.

Prikupljeni podaci bit će dostavljeni voditelju obrade vaših podataka i njihovom službeniku za zaštitu podataka radi obrade ovih zahtjeva.

Čuvaju se tijekom vremena analize i odgovora na isti.Imate pravo pristupa, ispravka i brisanja vaših osobnih podataka. Također se možete usprotiviti obradi vaših podataka.

Za ostvarivanje ovih prava ili za bilo kakva pitanja o obradi vaših podataka, morate ispuniti ovaj obrazac.

Ako smatrate, nakon što nas kontaktirate, da se vaša prava na "Zaštitu podataka" ne poštuju, možete podnijeti pritužbu nadležnom tijelu za zaštitu podataka.